Loading...
Loading...
Conexeu Sciences Inc.
Conexeu Sciences Inc.. Spoken Alpha tracks CNXU's earnings calls, guidance changes, and executive accountability over time.
Spoken Alpha tracks CNXU's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters with 50% positive reaction rate
SampleConsistent execution against consensus with the stock following through is the cleanest signal a guidance regime is calibrated. Worth watching for the inflection where execution deteriorates relative to the bar.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for CNXU.
curl https://api.spokenalpha.com/v1/companies/CNXU| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $3.89 | $2.85 | +36.6% | +7.1% | +5.2% |
| Q4 FY2026 | $4.21 | $2.99 | +40.8% | -0.4% | +0.8% |
| Q3 FY2026 | $3.91 | $2.88 | +35.8% | +6.7% | +8.7% |
| Q2 FY2026 | $4.18 | $2.98 | +40.2% | +1.8% | +1.0% |
| Q1 FY2025 | $4.08 | $3.10 | +31.7% | +2.7% | +4.4% |
| Q4 FY2025 | $4.61 | $3.17 | +45.5% | -4.5% | -3.5% |
| Q3 FY2025 | $4.32 | $3.02 | +42.9% | -2.5% | -0.8% |
| Q2 FY2025 | $4.61 | $3.22 | +43.2% | -2.2% | -1.4% |
| Q1 FY2024 | $4.06 | $3.01 | +35.0% | +4.0% | +6.1% |
| Q4 FY2024 | $4.75 | $3.25 | +46.2% | -1.0% | -3.9% |